India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The Waterman of India is a title for someone who works to solve water problems…
The 2009 ICC Champions Trophy, also known as the "Mini World Cup," was held in…
Cardamom is a popular spice grown in India, known for its unique aroma and flavor.…
IndiGo's CSR initiative, IndiGoReach, has launched the Zero Waste Airport Project at Indore Airport, in…
On December 25, 2024, Defence Secretary Rajesh Kumar Singh launched the Rashtraparv Website and Mobile…
In 2024, numerous prestigious awards and honors were given to individuals and organizations for their…